Related Experiment Video
Updated: Jun 14, 2025
10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.3K
Exploring the Spectrum of Long Non-Coding RNA CARMN in Physiological and Pathological Contexts
Hui Li1, Chuannan Sun1, Bin Luo1
1Department of Biochemistry and Molecular Biology, Shenzhen University Medical School, Shenzhen 518060, China.
Biomolecules
|August 29, 2024
Summary
Cardiac mesoderm enhancer-associated non-coding RNA (CARMN) is vital for cardiovascular health and acts as a tumor suppressor. This review explores CARMN
Area of Science:
- Molecular Biology
- Genetics
- Cardiovascular Research
Background:
- Cardiac mesoderm enhancer-associated non-coding RNA (CARMN) is an evolutionarily conserved long non-coding RNA (lncRNA).
- CARMN hosts the miR143/145 cluster and is crucial for cardiovascular cell differentiation and vascular smooth muscle cell (VSMC) homeostasis.
- Dysregulation of CARMN is implicated in cardiovascular diseases and cancer progression.
Purpose of the Study:
- To provide a comprehensive review of CARMN's roles, evolutionary conservation, and regulatory mechanisms.
- To examine CARMN's implications in cardiovascular diseases and various cancers.
- To highlight CARMN's potential as a diagnostic biomarker and therapeutic target.
Main Methods:
- Literature review and synthesis of existing research on CARMN.
- Analysis of CARMN's expression patterns and regulatory networks.
- Evaluation of CARMN's involvement in disease pathogenesis.
Main Results:
- CARMN is essential for normal cardiovascular physiology and VSMC function.
- CARMN acts as a tumor suppressor in multiple cancer types.
- CARMN is associated with the progression of atherosclerosis, abdominal aortic aneurysm, and chronic heart failure.
Conclusions:
- CARMN plays a dual role in cardiovascular health and cancer suppression.
- Further translational research is needed to leverage CARMN's clinical potential for diagnosis and treatment.
- CARMN represents a promising biomarker and therapeutic target for cardiovascular diseases and cancer.
More Related Videos
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:20Types of RNA
5.7K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
5.7K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
02:22Regulated mRNA Transport
6.3K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.3K
01:32RNA Splicing
56.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.2K